Copyright
©The Author(s) 2020.
World J Clin Oncol. Oct 24, 2020; 11(10): 809-835
Published online Oct 24, 2020. doi: 10.5306/wjco.v11.i10.809
Published online Oct 24, 2020. doi: 10.5306/wjco.v11.i10.809
Table 5 Invasive and noninvasive diagnostic procedures in cancer patients with acute respiratory failure[5]
Diagnostic procedure | Comments |
Blood cultures | Hospital-acquired bacteria |
Multislice or high-resolution CT scan | In most cases without contrast media; MRI if a pulmonary CT scan is not feasible |
Echocardiography | Cardiac evaluation |
Sputum examination | Bacteria; Fungi; Mycobacteria |
Induced sputum | Pneumocystis jiroveci |
Nasopharyngeal aspirates or nasal swabs | Adenovirus, metapneumovirus, coronavirus, parainfluenza virus types 1, 2, 3 and 4; influenza virus types A and B, respiratory syncytial virus A and B; rhinovirus A, B, and C; bocavirus and enterovirus |
Polymerase chain reaction blood test | Herpesviridae; Cytomegalovirus; Epstein-Barr virus |
Circulating Aspergillus galactomannan | Aspergillus spp. |
Serologic tests | Chlamydia pneumoniae; Mycoplasma pneumoniae; Legionella pneumophila |
Urine antigen | Legionella pneumophila; Streptococcus pneumoniae |
BAL (mandatory) | (1) Cytospin preparation including Giemsa stain for cytological diagnostics and Gram stain; (2) Quantitative or semi-quantitative bacteriological cultures including culture media to detect Legionella spp., mycobacteria and fungi; (3) Calcofluor white or equivalent stain (assessment of fungi); (4) Quantitative (if possible) PCR for Pneumocystis jirovecii; (5) Direct immunofluorescence test for Pneumocystis jirovecii; (6) Aspergillus antigen (Galactomannan ELISA); and (7) Mycobacterium tuberculosis PCR, atypical mycobacteria |
BAL (optional) | (1) PCR for cytomegalovirus, respiratory syncytial virus, influenza A/B virus, parainfluenza virus, human metapneumovirus, adenovirus, varicella zoster virus, and Pneumocystis jirovecii (quantitative); and (2) Aspergillus antigen (Galactomannan ELISA); Panfungal or Aspergillus/ mucormycetes PCR |
Transbronchial biopsies | Not recommended in general in febrile neutropenic and/or thrombocytopenic patients as the first line procedure |
- Citation: Martos-Benítez FD, Soler-Morejón CD, Lara-Ponce KX, Orama-Requejo V, Burgos-Aragüez D, Larrondo-Muguercia H, Lespoir RW. Critically ill patients with cancer: A clinical perspective. World J Clin Oncol 2020; 11(10): 809-835
- URL: https://www.wjgnet.com/2218-4333/full/v11/i10/809.htm
- DOI: https://dx.doi.org/10.5306/wjco.v11.i10.809